This model’s premium predictions are primarily driven by Age, an engineered Age_BMI interaction, and AnyTransplants, with consistent signals across correlation, permutation importance, and SHAP/LIME analyses, and error profiles that vary by age group and health-risk segments.​

Data and target
The task predicts an insurance premium as a continuous outcome, evaluated with RMSE and visualized against actuals across demographic and clinical segments in the cohort dashboards shown.​

Features include demographics (Age, Age_Group, Height, Weight, BMI), conditions (Diabetes, BloodPressureProblems, AnyChronicDiseases), procedures (NumberOfMajorSurgeries, AnyTransplants), family history, allergies, and an engineered Age_BMI_Interaction, plus a composite Health_Risk_Score.​

Global importance (model-wide)
Permutation importance ranks Age highest, followed by Age_BMI_Interaction and AnyTransplants, indicating that shuffling these variables most degrades model performance; this suggests strong reliance on age and its interaction with body composition, plus transplant status signals.​

SHAP summary corroborates the same ordering: Age and Age_BMI_Interaction show the broadest SHAP value spread, while AnyTransplants exhibits large positive impacts for high-risk cases; mid-tier contributors include Weight and AnyChronicDiseases.​

Directionality and effect shape
SHAP color gradients indicate higher Age values generally increase predicted premiums (points with high feature value tend to have positive SHAP on the right), aligning with domain expectations of risk accumulation with age.​

The Age_BMI_Interaction shows that jointly high age and BMI amplify premiums beyond additive effects, consistent with interaction engineering and permutation ranking.​

AnyTransplants has distinctly positive SHAP contributions for affected individuals, reflecting substantial cost load associated with transplant history.​

Correlation sanity checks
Feature-to-target correlation shows strong positive correlation for Age with both actual and predicted premiums (Corr_Actual ≈ 0.72; Corr_Pred ≈ 0.76), suggesting the model captures age’s monotonic effect well.​

Lower correlations for Diabetes and BloodPressureProblems reflect modest linear relationships in the dataset; their modeled impacts are correspondingly smaller in permutation/SHAP.​

Local explanations (individual predictions)
LIME for a sample case highlights a dominant negative contribution when AnyTransplants ≤ 0.0 (i.e., absence reduces premium), while rules like Age_BMI_Interaction > 1422.81 and Age in 42–53 add strongly positive contributions; this aligns with SHAP’s local positive pushes for older, higher-BMI profiles.​

Additional local factors such as HistoryOfCancerInFamily > 0.0 and AnyChronicDiseases > 0.0 contribute positively, whereas lower BMI/Weight bins contribute slightly negative, demonstrating case-by-case balancing of risk signals.​

Segment performance
RMSE by Age Group shows highest error for Young (0–25) and elevated error for Senior (60+), while Adult (26–40) is lowest, implying the model generalizes best to mid-age distribution and struggles on tails where variance or sample size differs.​

Diabetes status segments show slightly higher RMSE for those with diabetes than without, which may indicate heteroscedasticity or under-modeled interactions specific to metabolic risk.​

Consistency across methods
Agreement across permutation importance and SHAP on the top three drivers increases confidence in the feature ranking and model reliance patterns, reducing the chance that importance is an artifact of a single method.​

Correlation panels and local LIME rules point in the same direction for Age, chronic disease flags, and transplant history, reinforcing interpretability coherence at global and local levels.​

Risk and fairness considerations
Heavy reliance on Age can introduce age-related pricing disparities; auditing subgroup RMSE and calibration by age bands is appropriate and already partly visualized, suggesting the need for targeted recalibration on young and senior groups.​

Clinical features like AnyTransplants and AnyChronicDiseases represent legitimate cost signals, but monitoring for proxy effects via correlated socio-demographic variables is advised using SHAP-based subgroup drift checks.​

Actionable improvements
Model: add monotonic constraints for Age and possibly BMI if using tree-based learners to enforce clinically plausible trends and improve generalization on extremes.​

Features: explore spline terms or gradient-boosted interaction detection to better capture non-linearities that raise RMSE in Young and Senior segments; validate and possibly refine the Age_BMI_Interaction thresholding used in local rules.​

Evaluation: implement calibration curves and quantile loss diagnostics per segment; expand error analysis to comorbidity clusters (e.g., diabetes + hypertension) where residuals may remain structured.​

Executive summary
What drives predictions: Age, Age_BMI_Interaction, and AnyTransplants are the dominant levers, with consistent evidence across SHAP and permutation importance.​

How they act: higher age, higher age×BMI, and presence of transplants push premiums up; absence of transplant and lower BMI/weight pull them down locally, as seen in LIME and SHAP.​

Where the model struggles: error is highest in Young and elevated in Senior segments; diabetes subgroup shows modestly higher RMSE, pointing to opportunities for feature refinement and calibration.​

Appendix: figure map
Correlation panel: global sanity check of linear relationships and model capture quality for key features and predictions.​

LIME local plot: rule-based contributions for a single case, illustrating direction and magnitude of feature effects.​

Segment dashboards: RMSE by Age Group, Diabetes, and Health Risk, plus actual vs predicted bars by segment.​

SHAP summary: global + local distribution of feature impacts and value-color encoding for directionality.​

Permutation importance: ranked global importance; top-3 features list consistent with SHAP.​
